Paper40313508
Developing a predictive model for blood-brain-barrier permeability to explore relevance of in vitro neurotoxicity data for in vivo risk assessment.
Illa SE and 3 others. Front Toxicol, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Developing a predictive model for blood-brain-barrier permeability to explore relevance of in vitro neurotoxicity data for in vivo risk assessment. Papers, record 40313508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40313508
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Developing a predictive model for blood-brain-barrier permeability to explore relevance of in vitro neurotoxicity data for in vivo risk assessment.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DK135621 | NIDDK NIH HHS | United States | R01DK135621 | PubMed | NIH RePORTER |
| R01 HL122770 | NHLBI NIH HHS | United States | R01HL122770 | PubMed | NIH RePORTER |
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33662518 | Effective exposure of chemicals in in vitro cell systems: A review of chemical distribution models. | Toxicol In Vitro | 2021 | https://conductscience.org/library/papers/33662518 | PubMed |
| 2 | 29170977 | Species differences and mechanism of action of A3 adenosine receptor allosteric modulators. | Purinergic Signal | 2018 | https://conductscience.org/library/papers/29170977 | PubMed |
| 3 | 20833708 | The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and man. | Toxicol Sci | 2010 | https://conductscience.org/library/papers/20833708 | PubMed |
| 4 | 16417033 | Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data. | Crit Rev Toxicol | 2005 | https://conductscience.org/library/papers/16417033 | PubMed |
| 5 | 20635475 | Application of PAMPA-models to predict BBB permeability including efflux ratio, plasma protein binding and physicochemical parameters. | Int J Pharm | 2010 | https://conductscience.org/library/papers/20635475 | PubMed |
| 6 | 10807556 | Pulmonary toxicity and carcinogenicity of trichloroethylene: species differences and modes of action. | Environ Health Perspect | 2000 | https://conductscience.org/library/papers/10807556 | PubMed |
| 7 | 29634986 | Use of physiologically based kinetic modelling-facilitated reverse dosimetry to convert in vitro cytotoxicity data to predicted in vivo liver toxicity of lasiocarpine and riddelliine in rat. | Food Chem Toxicol | 2018 | https://conductscience.org/library/papers/29634986 | PubMed |
| 8 | 31532525 | Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization. | Toxicol Sci | 2020 | https://conductscience.org/library/papers/31532525 | PubMed |
| 9 | 36691848 | Cell culture: in vitro model system and a promising path to in vivo applications. | J Histotechnol | 2023 | https://conductscience.org/library/papers/36691848 | PubMed |
| 10 | 26344358 | Tuning the predictive capacity of the PAMPA-BBB model. | Eur J Pharm Sci | 2015 | https://conductscience.org/library/papers/26344358 | PubMed |
| 11 | 28872681 | Development of a direct contact astrocyte-human cerebral microvessel endothelial cells blood-brain barrier coculture model. | J Pharm Pharmacol | 2017 | https://conductscience.org/library/papers/28872681 | PubMed |
| 12 | 31356915 | Profiling 58 compounds including cosmetic-relevant chemicals using ToxRefDB and ToxCast. | Food Chem Toxicol | 2019 | https://conductscience.org/library/papers/31356915 | PubMed |
| 13 | 32927283 | Evaluating consumer exposure to disinfecting chemicals against coronavirus disease 2019 (COVID-19) and associated health risks. | Environ Int | 2020 | https://conductscience.org/library/papers/32927283 | PubMed |
| 14 | 21071550 | Toxic influence of organophosphate, carbamate, and organochlorine pesticides on cellular metabolism of lipids, proteins, and carbohydrates: a systematic review. | Hum Exp Toxicol | 2011 | https://conductscience.org/library/papers/21071550 | PubMed |
| 15 | 28470333 | Extracorporeal perfusion of isolated organs of large animals - Bridging the gap between in vitro and in vivo studies. | ALTEX | 2018 | https://conductscience.org/library/papers/28470333 | PubMed |
| 16 | 38108064 | Development and validation of PAMPA-BBB QSAR model to predict brain penetration potential of novel drug candidates. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/38108064 | PubMed |
| 17 | 27016491 | Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I. | Food Chem Toxicol | 2016 | https://conductscience.org/library/papers/27016491 | PubMed |
| 18 | 25542610 | Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis. | Eur J Pharm Sci | 2015 | https://conductscience.org/library/papers/25542610 | PubMed |
| 19 | 39033510 | Discovery Phase Agrochemical Predictive Safety Assessment Using High Content In Vitro Data to Estimate an In Vivo Toxicity Point of Departure. | J Agric Food Chem | 2024 | https://conductscience.org/library/papers/39033510 | PubMed |
| 20 | 22667820 | Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results. | Crit Rev Toxicol | 2012 | https://conductscience.org/library/papers/22667820 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42909160 | Static or microfluidic? A comparative pilot study of an in vivo-in vitro validated human iPSC-derived blood-brain barrier model for neurotoxicity hazard assessment. | NAM J | 2026 | https://conductscience.org/library/papers/42909160 | PubMed |
| 42038106 | Towards learning and memory risk assessment with human brain organoids: barriers and opportunities. | Front Toxicol | 2026 | https://conductscience.org/library/papers/42038106 | PubMed |
| 41878011 | In Vitro BBB triculture assay and preliminary computational model development to predict brain exposure. | Front Toxicol | 2026 | https://conductscience.org/library/papers/41878011 | PubMed |
| 41270976 | Informing development of brain cancer therapies within "preclinical trials" using ex vivo patient tumors. | Adv Drug Deliv Rev | 2026 | https://conductscience.org/library/papers/41270976 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40313508
GET https://conductscience.org/api/papers/v1/40313508/references?page=2